Search

Author/Creator Mack, Philip C.

1. A phase 2 cooperative group adjuvant trial using a biomarker‐based decision algorithm in patients with stage I non‐small cell lung cancer (SWOG‐0720, NCT00792701). Issue 15 (18th April 2014)

Authors:
Bepler, Gerold; Zinner, Ralph G.; Moon, James; Calhoun, Royce; Kernstine, Kemp; Williams, Charles C.; Mack, Philip C.; Oliveira, Vasco; Zheng, Zhong; Stella, Philip J.; Redman, Mary W.; Gandara, David R.
Journal:
Cancer
Issue:
Volume 120:Issue 15(2014)
Page Start:
2343
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2 cooperative group adjuvant trial using a biomarker‐based decision algorithm in patients with stage I non‐small cell lung cancer (SWOG‐0720, NCT00792701). Issue 15 (18th April 2014)

Authors:
Bepler, Gerold; Zinner, Ralph G.; Moon, James; Calhoun, Royce; Kernstine, Kemp; Williams, Charles C.; Mack, Philip C.; Oliveira, Vasco; Zheng, Zhong; Stella, Philip J.; Redman, Mary W.; Gandara, David R.
Journal:
Cancer
Issue:
Volume 120:Issue 15(2014)
Page Start:
2343
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer. Issue 4 (9th December 2022)

Authors:
de Miguel‐Perez, Diego; Russo, Alessandro; Gunasekaran, Muthukumar; Buemi, Francesco; Hester, Lisa; Fan, Xiaoxuan; Carter‐Cooper, Brandon A.; Lapidus, Rena G.; Peleg, Ariel; Arroyo‐Hernández, Marisol; Cardona, Andres F.; Naing, Aung; Hirsch, Fred R.; Mack, Philip C.; Kaushal, Sunjay; Serrano, Mar...
Journal:
Cancer
Issue:
Volume 129:Issue 4(2023)
Page Start:
521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Brief Reports - SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. Issue 3 (March 2016)

Authors:
Lara, Primo N.; Moon, James; Hesketh, Paul J.; Redman, Mary W.; Williamson, Stephen K.; Akerley, Wallace L.; Hirsch, Fred R.; Mack, Philip C.; Gandara, David R.
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial. Issue 8 (8th October 2014)

Authors:
Goldkorn, Amir; Ely, Benjamin; Tangen, Catherine M.; Tai, Yu‐Chong; Xu, Tong; Li, Hongli; Twardowski, Przemyslaw; Veldhuizen, Peter J. Van; Agarwal, Neeraj; Carducci, Michael A.; Monk, J. Paul; Garzotto, Mark; Mack, Philip C.; Lara, Primo; Higano, Celestia S.; Hussain, Maha; Vogelzang, Nicholas J...
Journal:
International journal of cancer
Issue:
Volume 136:Issue 8(2015:Apr. 15)
Page Start:
1856
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non–Small-Cell Lung Cancer. (2021)

Authors:
McCoach, Caroline E.; Yu, Aiming; Gandara, David R.; Riess, Jonathan W.; Vang, Daniel P.; Li, Tiahong; Lara, Primo N.; Gubens, Matthew; Lara, Frances; Mack, Philip C.; Beckett, Laurel A.; Kelly, Karen
Journal:
JCO precision oncology
Issue:
Volume 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET‐Positive Non‐Small‐Cell Lung Cancer. (December 2021)

Authors:
McCoach, Caroline E.; Yu, Aiming; Gandara, David R.; Riess, Jonathan W.; Vang, Daniel P.; Li, Tiahong; Lara, Primo N.; Gubens, Matthew; Lara, Frances; Mack, Philip C.; Beckett, Laurel A.; Kelly, Karen
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗